Dr. Martens plc (LON:DOCS - Get Free Report) shot up 25.8% during mid-day trading on Thursday . The stock traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares traded hands during mid-day trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada dropped their price target on Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating on the stock in a report on Monday, May 19th.
Get Our Latest Stock Report on DOCS
Dr. Martens Price Performance
The company has a market cap of £795.54 million, a P/E ratio of 11.62, a PEG ratio of 6.40 and a beta of 0.11. The company has a fifty day simple moving average of GBX 55.34 and a 200-day simple moving average of GBX 62.91. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens (LON:DOCS - Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, sell-side analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's dividend payout ratio (DPR) is currently 42.53%.
Insider Buying and Selling at Dr. Martens
In other Dr. Martens news, insider Giles Wilson acquired 32,640 shares of the firm's stock in a transaction that occurred on Tuesday, March 25th. The stock was purchased at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,857.07). Insiders have bought a total of 33,206 shares of company stock valued at $1,792,771 in the last three months. 4.36% of the stock is currently owned by company insiders.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Further Reading
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
